Direct-Acting Antivirals Not Linked to Liver Cancer Recurrence
Results of the largest study of its kind may help quell longstanding controversy surrounding the impact of DAA therapy on recurrence of HCC.
Source: ConsultantLive - Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news
More News: Cancer | Cancer & Oncology | Hepatitis | Hepatitis C | Internal Medicine | Liver | Study | Urology & Nephrology